NovaBridge Biosciences NBP
NASDAQ NBP
$1.36 +0.02 (+1.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Price to Sales (2023)

Updated

NovaBridge Biosciences' (NBP) Price to Sales was 0.76 for Q4 2023, up 40.0% from the prior quarter.

Analysis

NovaBridge Biosciences (NBP) Price to Sales (2023) Analysis & Trends

For FY2023, Price to Sales at NovaBridge Biosciences was 279.01, up 8.5% from FY2022.

  • By year, Price to Sales came in at 257.21 in FY2022 (-18.4%), 315.34 in FY2021 and 13.38 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 NovaBridge Biosciences 149.78 Mn 149.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 0.76
Sep 30, 2023 0.54
Jun 30, 2023 1.22
API Access

NovaBridge Biosciences Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=NBP&period=max&api_key=YOUR_API_KEY